Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering of 20,000,000 Class A ordinary shares at $10.00 per share. The shares began ...

Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, ...

In a recent blog post, OpenAI CEO Sam Altman said that as OpenAI continues to advance it has moved beyond research to product ...

In a report released yesterday, Ross Osborn from Cantor Fitzgerald reiterated a Buy rating on Avita Medical (RCEL – Research Report), with a ...

Fintel reports that on January 6, 2025, Cantor Fitzgerald initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a Overweight ...

Lucid Group Inc (LCID) stock saw a decline, ending the day at $3.18 which represents a decrease of $-0.15 or -4.50% from the prior close of $3.33. The stock opened at $3.4 and touched a low of $3.15 ...

Cantor Fitzgerald began coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Free Report) in a report issued on Tuesday morning, Marketbeat Ratings reports. The firm issued an overweight ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it priced its initial public offering of 20,000,000 Class A ordinary shares at $10.00 per share. The shares are ...

Cantor Fitzgerald has recently initiated Aquestive Therapeutics Inc (AQST) stock to Overweight rating, as announced on December 17, 2024, according to Finviz. Earlier, on May 10, 2024, Leerink ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

KeyCorp upgraded shares of Acadia Healthcare (NASDAQ:ACHC – Free Report) from a sector weight rating to an overweight rating ...